Montse Muñoz

648 total citations
6 papers, 91 citations indexed

About

Montse Muñoz is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Cancer Research. According to data from OpenAlex, Montse Muñoz has authored 6 papers receiving a total of 91 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 2 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Cancer Research. Recurrent topics in Montse Muñoz's work include HER2/EGFR in Cancer Research (4 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Breast Cancer Treatment Studies (2 papers). Montse Muñoz is often cited by papers focused on HER2/EGFR in Cancer Research (4 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Breast Cancer Treatment Studies (2 papers). Montse Muñoz collaborates with scholars based in Spain, Chile and United States. Montse Muñoz's co-authors include José Miguel Escudero Fernández, Ramon Berenguer, Jordi García, José Maria Augé, Xavier Filella, Rafael Molina, José Trigo, Atanasio Pandiella, Eva Carrasco and Rosalía Caballero and has published in prestigious journals such as Tetrahedron Letters, Oncotarget and Clinical Chemistry and Laboratory Medicine (CCLM).

In The Last Decade

Montse Muñoz

6 papers receiving 90 citations

Peers

Montse Muñoz

ONCOL

CR

MB

RNMI

OC

Jeffrey Lau United States

Constantina Mateoiu Sweden

Andrea Lindgren Sweden

Glen J. Weiss United States

Shaobu Weng United States

Manuel Ruiz-Echarri Spain

Leonardo Forero United States

Desam Roda United Kingdom

Eric Bernstein United States

Ulrich Reiser Germany

Jeffrey Lau United States

Montse Muñoz

89 ×1.8

ONCOL

30 ×1.0

CR

40 ×1.9

MB

68 ×4.3

RNMI

23 ×1.4

OC

Citations per year, relative to Montse Muñoz Montse Muñoz (= 1×) peers Jeffrey Lau

Countries citing papers authored by Montse Muñoz

Since Specialization

Citations

This map shows the geographic impact of Montse Muñoz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Montse Muñoz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Montse Muñoz more than expected).

Fields of papers citing papers by Montse Muñoz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Montse Muñoz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Montse Muñoz. The network helps show where Montse Muñoz may publish in the future.

Co-authorship network of co-authors of Montse Muñoz

This figure shows the co-authorship network connecting the top 25 collaborators of Montse Muñoz. A scholar is included among the top collaborators of Montse Muñoz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Montse Muñoz. Montse Muñoz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Ciruelos, Eva, Álvaro Montaño, César A. Rodríguez, et al.. (2020). Phase III study to evaluate patient’s preference of subcutaneous versus intravenous trastuzumab in HER2‐positive metastatic breast cancer patients: Results from the ChangHER study (GEICAM/2012‐07). European Journal of Cancer Care. 29(4). e13253–e13253. 7 indexed citations

2.

Ocaña, Alberto, Marta Gil-Martín, Miguel Martín, et al.. (2017). A phase I study of the SRC kinase inhibitor dasatinib with trastuzumab and paclitaxel as first line therapy for patients with HER2-overexpressing advanced breast cancer. GEICAM/2010-04 study. Oncotarget. 8(42). 73144–73153. 24 indexed citations

3.

Molina, Rafael, José Miguel Escudero Fernández, Montse Muñoz, José Maria Augé, & Xavier Filella. (2012). Circulating levels of HER-2/neu oncoprotein in breast cancer. Clinical Chemistry and Laboratory Medicine (CCLM). 50(1). 5–21. 20 indexed citations

4.

Escaramís, Geòrgia, Sergi Vidal‐Sicart, M. Illa, et al.. (2010). Predicting Non-Sentinel Lymph Node Status in Breast Cancer Patients with Sentinel Lymph Node Involvement: Evaluation of Two Scoring Systems. The Breast Journal. 16(2). 134–140. 17 indexed citations

5.

García‐Estévez, Laura, Ignasi Tusquets, Montse Muñoz, et al.. (2007). Advanced breast cancer: chemotherapy phase III trials that change a standard. Anti-Cancer Drugs. 18(7). 843–859. 8 indexed citations

6.

Berenguer, Ramon, et al.. (1998). Enantioselective synthesis of α-hydroxy thioesters via oxazaborolidine-mediated reduction of α-phenylthio enones. Tetrahedron Letters. 39(15). 2183–2186. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact